Sacramento, CA — Sacramento, California

Sacramento, CA is a clinical research site located in Sacramento, California, United States 95825.

Crixeo Health Trust Score: 71/100 (FAIR). This profile has not yet been claimed by the site owner.

Sacramento, CA has participated in 10 clinical trials with 6 currently active.

Therapeutic areas: Diabetic Macular Edema (DME), Neovascular Age-related Macular Degeneration (NVAMD), Neovascular (Wet) Age-Related Macular Degeneration.

Sponsors: EyeBiotech Ltd., Ollin Biosciences, Inc., Alcon Research.

Sponsor Feasibility Report

Trust Score: 71/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Sacramento, CA?

Sacramento, CA has a Crixeo Trust Score of 71/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Sacramento, CA conducted?

Sacramento, CA has 10 clinical trials on record, with 6 currently active. Their work covers Diabetic Macular Edema (DME), Neovascular Age-related Macular Degeneration (NVAMD), Neovascular (Wet) Age-Related Macular Degeneration.

Is Sacramento, CA accredited by Crixeo Health?

Yes — Sacramento, CA holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Sacramento, CA?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.